OA Journal of Oncology (OAJO) is an open peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies related to breast cancer, lung cancer, gastrointestinal cancer, skin cancer, neck cancer, paediatric oncology, neurooncology as well as genitourinary cancer. OAJO aims at rapid publication of high quality results in cancer research while maintaining rigorous peer-review process. Our journal strives to publish the highest quality articles dedicated to clinical research. Our journal provides a multidisciplinary forum for translational and clinical oncology research in the areas of molecular pathology, genomics, with a specific focus on molecular targeted agents and novel immune therapies.
The scope of our journal covers: Benign Tumors, Cancer Chemotherapy, Paediatric Oncology, Cancer prevention, Molecular biology, Recent developments in tumor therapy, Radiation oncology, Apoptosis, Oncogenes, Angiogenesis, Metastasis, Cancer image and interventional diagnosis and therapy, Tumor markers, Chemotherapy, Radiotherapy and biotherapy, Veterinary and Comparative Oncology, Clinical Trials in Oncology and Cancer Nanotechnology.
All articles published by OA Publication are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. We make research free to access for everyone, everywhere. Our authors retain copyright of their work through a Creative Commons attribution license that clearly states how readers can copy, distribute, and use their attributed research, free of charge.
As authors of articles published in OA Publication you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the OA Publication terms and conditions.